Illumina Inc. (ILMN)

ILMN (NASDAQ:Drugs)
$71.02
neg -1.56
-2.15%
Today's Range: 70.68 - 72.68 | ILMN Avg Daily Volume: 1,352,700
Last Update: 05/22/13 - 2:30 PM EDT
Volume: 1,532,400
YTD Performance: 31.46%
Open: $72.38
Previous Close: $72.58
52 Week Range: $37.77 - $77.11
Oustanding Shares: 124,378,537
Market Cap: 9,089,583,484
6-Month Chart
TheStreet Ratings Grade for ILMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 7
Moderate Buy 0 0 0 0
Hold 7 7 7 8
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.06 2.06 2.06 2.19
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 97.44
Price Earnings Comparisons:
ILMN Sector Avg. S&P 500
97.44 97.40 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
49.72% 69.38% 85.15%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.80 0.72 0.20
Net Income 74.60 1.09 0.28
EPS 82.30 1.08 0.27
Earnings for ILMN:
EBITDA 0.31B
Revenue 1.15B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $0.39 $0.40 $1.60 $1.97
Number of Analysts 14 13 2 15
High Estimate $0.42 $0.44 $1.61 $2.10
Low Estimate $0.32 $0.35 $1.58 $1.78
Prior Year $0.40 $0.32 $1.59 $1.60
Growth Rate (Year over Year) -2.32% 24.52% 0.31% 23.55%
Update Chart
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
aviatelive
aviatelive: Illumina (aviate BUY): Read-through’s from LIFE’s proxy… http://t.co/6jM9Antz6K #aviateUS $ILMN
46 minutes ago from HootSuite
fezziwig2008
fezziwig2008: $Roche failed to acquire $ILMN, partnered $HALO-M Posard of $ILMN on $HALO board-$ILMN IDs the tumors that PEGPH20 treats w $ROCHE CTX hmm
1 hour ago from web
CatspawInv
CatspawInv: RT @CaptainFuture__: $SQNM For #AngelinaJolie (and the rest of us, too) the future of genetic medicine is now http://t.co/IQZISl3uOk #NIPT $ILMN $PKI $LH
4 hours ago from web
CaptainFuture__
CaptainFuture__: $SQNM For #AngelinaJolie (and the rest of us, too) the future of genetic medicine is now http://t.co/IQZISl3uOk #NIPT $ILMN $PKI $LH
4 hours ago from web
CaptainFuture__
CaptainFuture__: RT @SeekingAlpha: 6 Ways You Can Profit From Molecular Diagnostics http://t.co/hbjA8oh1vC $EXAS $GHDX $ILMN $LLY $MYGN $NSPH $QGEN $SQNM
5 hours ago from web
beststockiq
beststockiq: RT @SeekingAlpha: 6 Ways You Can Profit From Molecular Diagnostics http://t.co/hbjA8oh1vC $EXAS $GHDX $ILMN $LLY $MYGN $NSPH $QGEN $SQNM
5 hours ago from web
SeekingAlpha
SeekingAlpha: 6 Ways You Can Profit From Molecular Diagnostics http://t.co/hbjA8oh1vC $EXAS $GHDX $ILMN $LLY $MYGN $NSPH $QGEN $SQNM
5 hours ago from Seeking Alpha
micenter
micenter: Illumina $ILMN Could Fall Through $71.29 Support Level ( http://t.co/WlJDIsiEj7 )
5 hours ago from Marketintelligencecenter.com
CaptainFuture__
CaptainFuture__: $SQNM Maternit21 @ CBS Maternity Test Reveals More About Unborn Babies Earlier In Pregnancy http://t.co/X52eehzsXI $ILMN $PKI $LH $DGX NIPT
6 hours ago from web
CaptainFuture__
CaptainFuture__: $SQNM designer babies tonight at 11 on CBS http://t.co/EAQVWvDyWz $ILMN $PKI $LH $DGX $BRLI #NIPT #prenataltesting #maternit21 #noninvasive
12 hours ago from web

bullishIllumina estimates, target increased at Credit Suisse

Apr 23, 2013 | 8:07 AM EDT

ILMN estimates were raised through 2015, Credit Suisse said. Company can likely gain market share from its top competitor. Outperform rating and new $72 price target. 

bullishIllumina price target and estimates increased at UBS

Apr 23, 2013 | 8:00 AM EDT

ILMN earnings estimates increased through 2014 given the first quarter beat, said UBS. The current earnings guidance seems conservative given recent momentum.  Price target is now $67.

bullishIllumina upgraded at UBS

Mar 1, 2013 | 8:16 AM EST

ILMN was upgraded to Buy from Neutral, UBS said. $61 price target. Re focus on commecial strength should drive upside. 

Going Their Own Ways

By

Robert Moreno

 | Feb 11, 2013 | 1:30 PM EST

These two stocks have been consolidating and now appear ready to move in opposite directions.

bearishIllumina downgraded at Wedbush

Jan 4, 2013 | 8:25 AM EST

Shares of ILMN downgraded to Neutral from Outperform, Wedbush said. $52 price target. Diminished risk/reward due to gain in share price.

bullishIllumina upgraded at Piper

Jan 4, 2013 | 7:44 AM EST

ILMN was upgraded from Neutral to Overweight, Piper Jaffray said. $61 price target. Company can continue to gain market share in next-generation sequencing. 

bearishIllumina downgraded at Baird

Nov 26, 2012 | 6:54 AM EST

ILMN was downgraded from Outperform to Neutral, Robert Baird said. $54 price target. Company faces more near-term challenges. 

 

Off the Charts

By

Scott Redler

 | Oct 11, 2012 | 6:44 PM EDT

We are shifting from a multi-position, swing-trading approach to a shorter-term approach.

bullishIllumina upgraded at Leerink

Jul 23, 2012 | 7:44 AM EDT

ILMN was upgraded from Market Perform to Outperform, Leerink Swann said. Company has multiple potential catalysts. 

bullishIllumina added to Focus List at Credit Suisse

Jun 22, 2012 | 8:20 AM EDT

ILMN was placed on the U.S. focus list, according to Credit Suisse. Company is a market leader with its HiSeq machines. 

Columnist Conversation / Market Updates

We Would All LOVE to Get Out At the Top...
By

Robert Lang

 | May 22, 2013 | 2:43 PM EDT
...and we would all LOVE to get in at the bottom. But those two moments are so elusive, but I have heard stories of luc...

The VIX
By

Helene Meisler

 | May 22, 2013 | 2:30 PM EDT
It moved!
See more »

Our Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.